Cite
Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis.
MLA
Magota, Hirotoshi, et al. “Repeated Infusion of Mesenchymal Stem Cells Maintain the Condition to Inhibit Deteriorated Motor Function, Leading to an Extended Lifespan in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis.” Molecular Brain, vol. 14, no. 1, May 2021, p. 76. EBSCOhost, https://doi.org/10.1186/s13041-021-00787-6.
APA
Magota, H., Sasaki, M., Kataoka-Sasaki, Y., Oka, S., Ukai, R., Kiyose, R., Onodera, R., Kocsis, J. D., & Honmou, O. (2021). Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis. Molecular Brain, 14(1), 76. https://doi.org/10.1186/s13041-021-00787-6
Chicago
Magota, Hirotoshi, Masanori Sasaki, Yuko Kataoka-Sasaki, Shinichi Oka, Ryo Ukai, Ryo Kiyose, Rie Onodera, Jeffery D Kocsis, and Osamu Honmou. 2021. “Repeated Infusion of Mesenchymal Stem Cells Maintain the Condition to Inhibit Deteriorated Motor Function, Leading to an Extended Lifespan in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis.” Molecular Brain 14 (1): 76. doi:10.1186/s13041-021-00787-6.